<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39553103</PMID><DateRevised><Year>2024</Year><Month>11</Month><Day>18</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>16</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>Spontaneous Resolution of Post-COVID-19-Associated Sacral Neuromodulation Device Dysfunction and Overactive Bladder Symptoms: A Report of Two Cases.</ArticleTitle><Pagination><StartPage>e71722</StartPage><MedlinePgn>e71722</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e71722</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.71722</ELocationID><Abstract><AbstractText>Sacral neuromodulation (SNM) is an effective third-line therapy for overactive bladder (OAB). COVID-19 may have a temporary negative effect on SNM function. We describe two cases of increased sensory thresholds and loss of SNM efficacy following COVID-19 infection. In both of these cases, SNM efficacy, sensory thresholds, and impedances were spontaneously restored after a few months without surgical intervention. Withholding surgical revision due to transient post-COVID-19-induced SNM impairment may be appropriate; however, further research is needed to elucidate the mechanism involved with COVID-19 interaction with SNM functionality.</AbstractText><CopyrightInformation>Copyright © 2024, Wong et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>Ryan</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Medicine, Dr. Kiran C. Patel College of Osteopathic Medicine, Nova Southeastern University, Fort Lauderdale, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sturgis</LastName><ForeName>Morgan R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Department of Urology, Rush University Medical Center, Chicago, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Langbo</LastName><ForeName>William A</ForeName><Initials>WA</Initials><AffiliationInfo><Affiliation>Department of Urology, Rush University Medical Center, Chicago, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adelstein</LastName><ForeName>Sarah A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Department of Urology, Rush University Medical Center, Chicago, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">covid-19</Keyword><Keyword MajorTopicYN="N">implant</Keyword><Keyword MajorTopicYN="N">overactive bladder</Keyword><Keyword MajorTopicYN="N">sacral neuromodulation</Keyword><Keyword MajorTopicYN="N">urinary incontinece</Keyword></KeywordList><CoiStatement>Human subjects: Consent was obtained or waived by all participants in this study. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: Sarah Adelstein is an investigator for Valencia Technologies.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>9</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>18</Day><Hour>6</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>18</Day><Hour>6</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39553103</ArticleId><ArticleId IdType="pmc">PMC11568847</ArticleId><ArticleId IdType="doi">10.7759/cureus.71722</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Prolonged impacts of COVID-19-associated cystitis: a study on long-term consequences. Wittenberg S, Vercnocke J, Chancellor M, Dhar S, Liaw A, Lucas S, Dhar N. World J Clin Cases. 2023;11:7987–7993.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10698398</ArticleId><ArticleId IdType="pubmed">38075566</ArticleId></ArticleIdList></Reference><Reference><Citation>Two-year outcomes of the ARTISAN-SNM study for the treatment of urinary urgency incontinence using the Axonics rechargeable sacral neuromodulation system. Pezzella A, McCrery R, Lane F, et al. Neurourol Urodyn. 2021;40:714–721.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7986436</ArticleId><ArticleId IdType="pubmed">33508155</ArticleId></ArticleIdList></Reference><Reference><Citation>Stimulation parameters for sacral neuromodulation on lower urinary tract and bowel dysfunction-related clinical outcome: a systematic review. Assmann R, Douven P, Kleijnen J, van Koeveringe GA, Joosten EA, Melenhorst J, Breukink SO. Neuromodulation. 2020;23:1082–1093.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7818464</ArticleId><ArticleId IdType="pubmed">32830414</ArticleId></ArticleIdList></Reference><Reference><Citation>A prospective, multicenter, international study to explore the effect of three different amplitude settings in female subjects with urinary urge incontinence receiving interstim therapy. Elterman D, Ehlert M, De Ridder D, et al. Neurourol Urodyn. 2021;40:920–928.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8248091</ArticleId><ArticleId IdType="pubmed">33645864</ArticleId></ArticleIdList></Reference><Reference><Citation>Cochlear implant failure following COVID 19: report of two cases. Saki N, Karimi M, Bayat A. Am J Otolaryngol. 2021;42:102910.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7825864</ArticleId><ArticleId IdType="pubmed">33513478</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudden occurrence of pacemaker capture failure during irreversible electroporation ablation for prostate cancer in post-COVID-19 patient: a case report. Chae MS, Lee N, Koh HJ. Medicina (Kaunas) 2022;58:1407.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9607448</ArticleId><ArticleId IdType="pubmed">36295568</ArticleId></ArticleIdList></Reference><Reference><Citation>Incidence of new or worsening overactive bladder among patients with a prior SARS-CoV-2 infection: a cohort study. Hoang Roberts L, Zwaans BM, Peters KM, Chancellor M, Padmanabhan P. Eur Urol Open Sci. 2022;46:68–74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9554342</ArticleId><ArticleId IdType="pubmed">36245790</ArticleId></ArticleIdList></Reference><Reference><Citation>Evaluation of overactive bladder symptoms in patients recovering from post-acute COVID-19 syndrome. Zachariou A, Sapouna V, Kaltsas A, et al. J Multidiscip Healthc. 2022;15:2447–2452.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9618246</ArticleId><ArticleId IdType="pubmed">36320554</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>